Corcept Therapeutics Incorporated (0I3Q)
Market Closed
16 Oct, 03:30 PM
$
108. 61
-4.98
-4.3842%
$
5.86B Market Cap
- P/E Ratio
- Div Yield
898 Volume
- Eps
$ 113.59
Previous Close Want to track 0I3Q and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Corcept Therapeutics Incorporated (0I3Q) Statistics
Valuation metrics
Market Cap 5.86B
Enterprise value 11.81B
Trailing P/E (ttm) 211.85
Forward P/E -
PEG ratio -3.61
Price/Sales (ttm) 14.33
Price/Book (mrq) 16.45
Enterprise Value/Revenue 14.21
Enterprise Value/EBITDA 410.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 746
Average volume (90 days) 1.07K
Price summary
52-Week low 28.67
52-Week high 126.57
Beta -
50-Day moving average 115.15
200-Day moving average 87.23
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.01%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 7.88
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.52
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.92
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 2.86%
Book value per share (mrq) 6.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
